Veriheal

MARCH 1, 2022

The first legal psilocybin therapy program to take shape in America is slowly progressing in Oregon. Kate Brown conducts regularly scheduled monthly meetings with a goal of shaping the nation’s first Psilocybin therapy program. Oregon’s Psilocybin Therapy Program: Advisory Board Hard at Work. ” . .”

Therapy 98

Therapy Programs Microdosing Medicine 98

Veriheal

FEBRUARY 21, 2023

As medicinal and recreational cannabis legalization continues to sweep across the United States, a recent study paints a concerning portrait of many states denying or restricting medical marijuana (MMJ) access. Nugg MD’s report suggests there is more to unpack when analyzing healthcare disparities related to MMJ access.

Access 98

Access Patients Chronic Pain Conditions 98

Medical Marijuana Program Connection

MARCH 8, 2023

Corganics, a clinical cannabinoid (CBD) company, announced a patient access partnership with OrthoLoneStar, an independent orthopedic practice in Texas. Read More

Access 52

Access Patients Therapy CBD 52

NORML

NOVEMBER 8, 2019

This year, we can and must succeed in passing this essential legislation and protecting the rights of veterans to access medical treatment and serving those who served us. Research published in the Journal of Psychoactive Drugs found a 75% reduction in Clinician-Administered Posttraumatic Scale scores following cannabis therapy.

Access 203

Access Marijuana Treatment Legislation 203

Cannabis Law Report

DECEMBER 14, 2022

13, 2022 (GLOBE NEWSWIRE) — The Alchemy Community Therapy Center, a 501(c)(3) non-profit which provides high-quality training and accessible psychedelic therapy to underserved communities, announced today that it has added three new board members, all leaders in the field, effective immediately. OAKLAND, Calif.,

Therapy 52

Therapy Access 52

Cannabis Law Report

DECEMBER 5, 2021

Revenue share payments will be based on North America sales of MDMA for use in MDMA-assisted therapy, will terminate after 8 years, and include a reciprocity payment structure that reduces payments once certain financial milestones are met. The safety and efficacy of MDMA-assisted therapy is currently under investigation.

Therapy 52

Therapy Access Research and Development Clinical Trials 52

Cannabis Law Report

MARCH 22, 2023

When psychedelic therapies begin to gain regulatory approval, they will need to be incorporated into the medical billing and coding system in a way that ensures equitable patient access, say experts.

Therapy 52

Therapy Treatment Conditions Access 52

Canna Law Blog

NOVEMBER 27, 2021

is expanding rapidly as numerous neuropharmaceutical companies look to be among the first-to-market potentially revolutionary therapies. In September, the Nikean Foundation announced a $5 million gift to create a psychedelic therapy research center at the University of Toronto. The post DMT Therapy: Coming to a Clinic Near You?

Therapy 88

Therapy Clinical Trials DEA Microdosing 88

NORML

FEBRUARY 13, 2019

Today, Senator Brian Schatz (D-HI) and Representative Barbara Lee (D-CA) introduced legislation, The Veterans Medical Marijuana Safe Harbor Act , to expand and facilitate medical cannabis access to military veterans suffering from chronic pain, PTSD, and other serious medical conditions.

Legislation 226

Legislation Access Chronic Pain Marijuana 226

NORML

NOVEMBER 1, 2019

Those suffering from chronic pain report significant improvements in health following the passage of medical cannabis access laws, according to data published in the journal Forum for Health Economics & Policy. Among state-licensed medical cannabis registrants, two out of three report consuming cannabis to mitigate pain conditions.

Access 172

Access Patients Chronic Pain Law 172

Veriheal

JUNE 7, 2021

Note: Veriheal does not support illegally consuming therapeutic substances like MDMA but acknowledges that it transpires because of the current illicit status of both, which we strive to change by advocating for research, legal access, and responsible consumption. Always consult a physician before attempting alternative therapies.

Therapy 92

Therapy Treatment Conditions Clinical Trials 92

Cannabis Law Report

OCTOBER 4, 2021

Advanced Illness , Oregon Psilocybin Advisory Board , Oregon Psilocybin Services Act , Psilocybin , Psilocybin Therapy , Psychedelics , Right To Try. Accordingly, it cannot be prescribed by a physician and it is not legally accessible to those who might benefit from it as a therapeutic treatment. Kathryn Tucker.

Therapy 52

Therapy Patients Law Clinical Trials 52

Cannabis Law Report

JUNE 21, 2022

They may be in need of oxygen therapy. People who obtain oxygen therapy can often see enhanced energy levels and good sleep, and improved quality of life. Who will need oxygen therapy? Our oxygen therapy Las Vegas is mostly given to people who cannot get enough oxygen naturally. Different types of oxygen therapies.

Therapy 52

Therapy Concentrates Conditions Sleep 52

Cannabis Law Report

MAY 19, 2022

.” Hartle, 54, is one of the very few Canadians to have received legal psychedelics psychotherapy for a mental health condition since Health Canada made it easier in January for health-care workers to access psilocybin — the hallucinogenic compound found in some mushrooms. ” Health Canada on Jan.

Therapy 52

Therapy Patients Treatment Clinical Trials 52

Cannabis Law Report

JUNE 16, 2021

Both parties to this new relationship are committed to excellence in clinical research and patient access to psychedelic medicine with a focus on naturally derived psilocybin. We are excited to explore the potential of emergent psychedelic therapies. ABOUT SANTÉ CANNABIS. Caution Regarding Forward-Looking Information.

Clinical Trials 104

Clinical Trials Therapy Research and Development Events 104

Cannabis Law Report

JANUARY 6, 2022

CNSX : FTRP; OTCMKTS : FTRPF), a global leader in the development and delivery of psychedelic therapies, today announced that it will begin making applications for Canadians in need to access psilocybin-assisted and MDMA-assisted therapy through Health Canada’s Special Access Program (SAP). Field Trip Health Ltd.

Access 52

Access Patients Therapy Conditions 52

Veriheal

FEBRUARY 18, 2021

But it’s acknowledged that it transpires because of the current illicit status, which we strive to change by advocating for research, legal access, and responsible consumption. The university has conducted research that studied the best music to include in psychedelic therapy. What is Psychedelic Therapy.

Therapy 52

Therapy Research and Development Collective Consumption 52

NORML

MAY 14, 2021

"The most vulnerable Mississippians will continue to be denied safe access to a therapy that could offer them significant relief from severely debilitating conditions.”. The post Mississippi: Supreme Court Nullifies Voter-Approved Medical Cannabis Initiative appeared first on NORML.

Therapy 245

Therapy Conditions Access Cannabis 245

Canna Law Blog

NOVEMBER 10, 2020

I was talking to another lawyer about last week’s vote by Oregonians to legalize psilocybin therapy here in the state. Public Law 115-176 (“Right to Try”) is a federal law enacted in 2018 that creates a uniform system for terminal patients seeking access to investigational treatments. It’s quite restrictive.

Therapy 79

Therapy Clinical Trials Decriminalization Patients 79

Cannabis Law Report

FEBRUARY 9, 2022

A group of Maryland senators recently filed a bill that would create a state fund that could be used to provide free access to psychedelics like psilocybin, MDMA and ketamine for military veterans suffering from post-traumatic stress disorder (PTSD), while also supporting research into their therapeutic potential. Marijuana Moment write.

Access 52

Access Therapy Legislation Marijuana 52

Cannabis Law Report

MARCH 8, 2021

The Canberra Times writes… ACT Greens’ MLA Johnathan Davis wants Canberra to be the first jurisdiction to provide an accessible… Read More. The post Greens MP hopes Canberra will be the first to introduce psychedelic assisted therapy first appeared on Cannabis Law Report.

Therapy 59

Therapy Access Law Cannabis 59

Cannabis Law Report

MAY 31, 2022

The governor of Maryland announced on Friday that he will allow a bill to create a state fund to provide “cost-free” access to psychedelics like psilocybin, MDMA and ketamine for military veterans suffering from post-traumatic stress disorder (PTSD) and traumatic brain injury to take effect without his signature. Marijuana Moment reports.

Access 52

Access Therapy Legislation Programs 52

Cannabis Law Report

AUGUST 3, 2022

Eight Canadians have filed a Charter challenge against the Government of Canada and the Minister of Health regarding patient access to psilocybin and psilocybin therapy. The challenge is supported by TheraPsil, a B.C.-based Read more.

Access 52

Access Patients Therapy Legalization 52

Cannabis Law Report

DECEMBER 11, 2021

The UK’s first and highest-rated medical cannabis clinic, Sapphire Medical Clinics , has today announced that it is reducing the cost of its consultations and appointments for patients enrolled through the Sapphire Access Scheme. The Sapphire Access Scheme will be open to an additional 2,000 patients in the UK.

Access 52

Access Patients Chronic Pain Treatment 52

Veriheal

APRIL 3, 2024

Naropa University in Boulder, Colorado, has created an exciting new initiative for students: a minor in psychedelic studies, designed to train those who want to practice psychedelic-assisted therapy and other related careers. It’s tailored for students interested in exploring past and contemporary uses of psychedelics.

Therapy 67

Therapy Education Programs Medicine 67

Veriheal

JUNE 22, 2021

Over the next decade, the United States could stand to see an explosion in the research of cannabinoid therapies. As the medical understanding of cannabinoid therapies and their actions become more advanced, hopefully, the United States federal government will be able to keep up and adjust laws pertaining to cannabis accordingly.

DEA 65

DEA Access Therapy Cannabinoids 65

Veriheal

FEBRUARY 14, 2024

Under the new measure, the Department of Human Services (DHS) will be able to offer licenses to psilocybin therapy centers with trained therapists and psychedelic facilitators. The goal is to ensure that psychedelic therapy remains safe, accessible, and affordable to those 21 and older.

Therapy 62

Therapy Legalization Research and Development Treatment 62

Cannabis Law Report

JUNE 28, 2021

Pharmaceutical and Medical Cannabis Leaders Zambon GmbH and Adven GmbH will Drive Medical Cannabis Supporting Treatments for Neurological Therapies. The aim of the agreement is to make medical cannabis treatments available to patients, with an initial focus on neurological therapies. It is expected to be worth USD 2.1

Access 105

Access Research and Development Pharmaceutical Therapy 105

Cannabis Law Report

APRIL 15, 2022

On Monday, a Maryland House of Delegates committee took up a Senate-passed bill to establish a state fund that could be used to provide “cost-free” access to psychedelics like psilocybin, MDMA , and ketamine to military veterans suffering from those all-too-common afflictions. The Beard Brothers site reports. Sarah Elfreth’s proposal (D).

Access 52

Access Therapy Legislation Policy 52

Cannabis Law Report

AUGUST 19, 2021

Cannim will sell its products in the EU medical markets through the Cantourage Fast Track Access Platform. We are excited to offer Cannim’s high-quality indica-dominant Lumir flowers in Europe and to further create access to the European market for medical cannabis from across the world through our platform. About Cantourage GmbH.

Access 98

Access Cultivation Patients Indica 98

Cannabis Law Report

JANUARY 6, 2022

This blog post will explain how psilocybin patenting and other factors could make Oregon’s psilocybin program prohibitively expensive for low-income patients, and how big pharma is maneuvering to monopolize psychedelic therapy. The FDA will likely refer to this data as it considers formal approval for psilocybin therapy and products.

Access 52

Access Patients Research and Development Treatment 52

Cannabis Law Report

APRIL 2, 2022

Founded in 2019, Roots to Thrive is Canada’s first and only multidisciplinary, non-profit healthcare practice to legally offer evidence-informed, multi-week group therapy programs that include psilocybin-assisted and ketamine-assisted group therapy sessions.

Therapy 52

Therapy Research and Development Programs Legalization 52

Cannabis Law Report

FEBRUARY 14, 2022

Our families and communities are suffering, and we urgently need access to preventative and curative medicines and medical care that is safe and effective. These ground-breaking treatments offer therapeutic access to either psilocybin (the active ingredient in ‘magic mushrooms’) or MDMA, a synthetic medicine.

Medicine 52

Medicine Access Therapy Treatment 52

Cannabis Law Report

JUNE 14, 2022

Those values guide our joint efforts to change perceptions about psychedelic assisted therapies, raise awareness of the scientific advances and, ultimately, bring better health to European citizens. Ketamine is already registered for the treatment of depression and in 2023, the FDA might approve an MDMA assisted therapy for PTSD.

Access 52

Access Therapy Clinical Trials Treatment 52

MMJ Recs

NOVEMBER 2, 2023

The real stories around medical marijuana (MMJ) are those of the patients who have experienced life-changing benefits from cannabis therapy. In this article, we’ll explore MMJ patient success stories in West Virginia and how cannabis therapy is positively impacting patients’ lives.

Patients 98

Patients Chronic Pain Therapy Treatment 98

Veriheal

APRIL 15, 2022

While most residents in these states only need to have a qualifying condition to get access, residents who belong to certain professions—such as healthcare workers—are prohibited from consumption regardless of medical need. Several council members are in support of allowing first responders access to the medical cannabis program in the state.

Access 52

Access THC Cannabis Therapy 52

MMJ Recs

FEBRUARY 27, 2024

Dispensaries serve as the primary access point for patients seeking medical marijuana products. Currently, Florida has a limited number of dispensaries strategically located across the state to ensure accessibility for patients with qualifying conditions. Medications, physical therapy, and lifestyle modifications are commonly employed.

Dispensary 93

Dispensary Legalization Marijuana Therapy 93